Recently, the National Clinical Research Center for Hematological Diseases, the Institute of Hematology of Peking University, and the Department of Hematology of Peking University People’s Hospital have all entered the Tongzhou Campus of Peking University People’s Hospital, and the Hematology Ward has been fully opened.
With the entry of advantageous disciplines and the opening of discipline wards, “big experts” will follow. After the opening of the ward, Professor Huang Xiaojun, director of the Institute of Hematology of Peking University, went to the Hematology Ward of Tongzhou Campus for rounds, carefully checked the signs of each inpatient, learned about the medical history in detail, and gave guidance on further treatment plans. “The opening of the wards in Tongzhou Campus not only provides services for the local people, but also effectively alleviates the shortage of beds in Xizhimen Campus.” As the dominant discipline of Peking University People’s Hospital, it is a well-known and well-known blood disease diagnosis and treatment center at home and abroad, all over the country There are countless blood disease patients who come here. As of now, all the blood wards in Tongzhou Campus have been fully booked.
In order to allow patients to be hospitalized as soon as possible, the hematology ward was opened in advance. “The medical staff in the Hematology Department are very nervous, but no matter how many difficulties we overcome, we must ensure the quality of medical care.” Professor Lu Jin of the Department of Hematology, Peking University People’s Hospital said. At present, there are 5 doctors and 7 nurses in the Hematology Ward of Tongzhou Campus. Under the leadership of Director Lu Jin, the Hematology Ward of the Tongzhou Branch of Peking University People’s Hospital conducts daily rounds. health education. During this period, relevant dietary guidance and educational manuals were also specially provided for patients with diabetes mellitus.
It is understood that the Institute of Hematology, Peking University initially had only 17 beds and two laminar flow beds, and the country’s first all-congruent hematopoietic stem cell transplantation was completed in the institute. Today, Peking University Blood Institute has become a national clinical medical research center with three platforms of diagnosis, treatment and transformation.
Peking University People’s Hospital and Tongzhou District of Beijing have in-depth cooperation to jointly build Tongzhou Campus. The first phase is planned to cover an area of 147 mu, with a construction area of 119,000 square meters and 800 beds to accommodate daily outpatient visits. 4000 people. Tongzhou Branch officially opened the clinic on December 18, 2021, and received attention, support and strong response from all walks of life.
As the “Double Unique” hospital (the only hospital under the jurisdiction of the National Health Commission and the only hospital affiliated to Peking University) introduced as a sub-center of the city, the Tongzhou Branch of Peking University People’s Hospital is a large-scale tertiary-grade hospital. To further promote the quality, expansion, co-construction and sharing of high-quality medical resources, we carefully plan the hospital space and scientifically arrange the development of disciplines, and comprehensively introduce national centers, academician teams, national key specialties and other advantageous disciplines into Tongzhou campus. Establish a diagnosis and treatment demonstration area based in Beijing, serving the Beijing-Tianjin-Hebei region, and radiating across the country, build an intersecting platform for basic research and medical technology research, and continuously explore comprehensive, coordinated, and sustainable high-quality medical treatment, teaching, scientific research, prevention, and management. development path.
(Editor in charge: Wu Shanshan)